(Q40309938)

19 September 2017

Insulin glulisine--a comprehensive preclinical evaluation (English)

1 reference

19 September 2017

Ingo Stammberger

1

1 reference

PubMed ID

16510354

19 September 2017

Gerhard Seipke

series ordinal

2

1 reference

PubMed ID

16510354

19 September 2017

Thomas Bartels

series ordinal

3

1 reference

19 September 2017

1 January 2006

1 reference

International Journal of Toxicology

19 September 2017

1 reference

19 September 2017

25

1 reference

19 September 2017

1

1 reference

19 September 2017

25-33

1 reference

Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes

19 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F10915810500488379

The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500488379

Insulin analogues and their potential in the management of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500488379

Insulin glulisine provides improved glycemic control in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500488379

ALS/Lt: a new type 2 diabetes mouse model associated with low free radical scavenging potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500488379

Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500488379

Insulin dependence of murine lymphoid T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500488379

A novel insulin analog with unique properties: LysB3,GluB29 insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500488379

LysB3, GluB29 insulin: a novel insulin analog with enhanced β-cell protective action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500488379

Logical analysis of timing-dependent receptor signalling specificity: application to the insulin receptor metabolic and mitogenic signalling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10915810500488379

10.1080/10915810500488379

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference

PubMed ID

16510354